Don't have an account?
Up to 40 percent of men diagnosed with prostate cancer will relapse12. GE Healthcare's advanced technology can help accurately and precisely characterize abnormal tissue, during follow up assessments.
Products
LOGIQ™ E10 Ultrasound Series
Next-generation, leadership ultrasound that adapts to your needs, today and into the future.
SIGNA™ PETMR with QuantWorks
Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.
References:
12. Prostate Cancer Recurrence [Internet]. ZERO - The End of Prostate Cancer. 2018 [cited 2 November 2018]. Available from:https://zerocancer.org/learn/survivors/recurrence/
JB04823XX